Healthcare - Biotechnology - NASDAQ - US
$ 0.374
-4.91 %
$ 2.35 M
Market Cap
-0.02
P/E
Price Target
Average
167.38%
Revenue Forecast
Estimate
309.48%
EBIT
Estimate
47.89%
Net Income
Estimate
21.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cyclacel Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CYCC of $1 , with forecasts ranging from a low of $1 to a high of $1 .
CYCC Lowest Price Target
Wall Street Target
1 USD
167.38%
CYCC Average Price Target
Wall Street Target
1 USD
167.38%
CYCC Highest Price Target
Wall Street Target
1 USD
167.38%
REVENUE FORECAST
Revenue Forecast Chart CYCC
EBIT FORECAST
EBIT Forecast Chart CYCC
NET INCOME FORECAST
Net Income Chart CYCC